scholarly article | Q13442814 |
P2093 | author name string | Clarke A | |
P2860 | cites work | A genome-wide search for human type 1 diabetes susceptibility genes | Q28247197 |
Psychosocial issues raised by a familial ovarian cancer register | Q33595562 | ||
Effectiveness and hazards of case finding for a high cholesterol concentration | Q35169329 | ||
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations | Q35180196 | ||
Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. | Q35889419 | ||
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? | Q36884264 | ||
Assessing possible hazards of reducing serum cholesterol | Q36884291 | ||
Widening inequality of health in northern England, 1981-91. | Q36885405 | ||
The prevention and management of autosomal recessive conditions. Main example: alpha 1-antitrypsin deficiency. | Q38738744 | ||
Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings | Q39520948 | ||
The shadow of genetic injustice | Q41082306 | ||
Insurance and genetic testing | Q41090842 | ||
Genetics and health care: a paradigm shift | Q41202881 | ||
DNA markers associated with high versus low IQ: the IQ Quantitative Trait Loci (QTL) Project | Q41484573 | ||
Screening for cardiovascular risk in general practice | Q42561047 | ||
Should we test children for "adult" genetic diseases? | Q45293856 | ||
Compliance with childhood cholesterol screening among members of a prepaid health plan | Q46324724 | ||
The limits of lifestyle: re-assessing 'fatalism' in the popular culture of illness prevention | Q47296319 | ||
Position paper on genetic discrimination Position paper on human genome initiative | Q47347481 | ||
Health promotion: the ethical dimension. | Q53659088 | ||
Individual or social responsibility for premature death? Current controversies in the British debate about health | Q56919672 | ||
Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome llq | Q60077042 | ||
Psychologic effects of the diagnosis and treatment of hypercholesterolemia: Lessons from case studies | Q67779028 | ||
Nature, nurture, and family predisposition | Q68278191 | ||
Growth failure. A complication of dietary treatment of hypercholesterolemia | Q69607074 | ||
The morbidity of cardiac nondisease in schoolchildren | Q72214713 | ||
Apolipoproteins and ischaemic heart disease: implications for screening | Q72662515 | ||
Prevention | Q72824526 | ||
P433 | issue | 6996 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 35-38 | |
P577 | publication date | 1995-07-01 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Population screening for genetic susceptibility to disease | |
P478 | volume | 311 |
Q40829945 | Acanthosis Nigricans as an early clinical proxy marker of increased risk of type II diabetes |
Q33805447 | Appraising organised screening programmes for testing for genetic susceptibility to cancer |
Q47198540 | Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation |
Q47601644 | Eugenics and the new genetics in Britain: examining contemporary professionals' accounts. |
Q53428468 | Genetic counselling for personalised medicine. |
Q51099419 | Genetic screening and haemoglobinopathies: ethics, politics and practice. |
Q33815299 | Genetic screening: A primer for primary care. |
Q37696824 | Genetic screening: a conceptual framework for programmes and policy-making |
Q40778567 | How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective. |
Q51119281 | Lay understanding of genetic disease: a British study of families attending a genetic counseling service. |
Q38239811 | Managing the ethical challenges of next-generation sequencing in genomic medicine |
Q51048022 | Prediction of psychological reactions to bone density screening for osteoporosis using a cognitive-behavioral model of health anxiety. |
Q40695057 | Predictive genetic testing in maturity-onset diabetes of the young (MODY). |
Q54066779 | Resisting revolution: generalism and the new genetics. |
Q35211643 | Social and psychological issues associated with the new genetics |
Q33688760 | Tensions between policy makers and general practitioners in implementing new genetics: grounded theory interview study |
Q34729058 | Variables that underlie cost efficacy of prenatal screening |
Search more.